Effect of vitamin D supplementation on incidence of bronchopulmonary dysplasia among preterm infants up to 36 weeks' gestational age.

What It Covers

Researchers studied Vitamin D, K2, Magnesium and Zinc and Copper (Supplement) in this review publication.

The purpose of this literature review was to determine the impact of vitamin D supplementation on BPD incidence among preterm infants born ≤36 weeks GA.

Why It Was Studied

Preterm infants, especially those born at a younger gestational age (GA), are at risk for developing bronchopulmonary dysplasia (BPD), which can lead to longer hospitalizations, chronic pulmonary morbidity, and mortality.

A literature search of the PubMed, CINAHL, SCOPUS, and Google Scholar databases was conducted searching for clinical studies published since 2014 that evaluated the effect of vitamin D supplementation on BPD incidence among preterm infants ≤36 weeks GA.

What Was Measured

A literature search of the PubMed, CINAHL, SCOPUS, and Google Scholar databases was conducted searching for clinical studies published since 2014 that evaluated the effect of vitamin D supplementation on BPD incidence among preterm infants ≤36 weeks GA.

The subject headings attached to it are Bronchopulmonary Dysplasia, Vitamin D, Infant, Premature, Dietary Supplements, Incidence, Vitamin D Deficiency and Gestational Age.

Author keywords: preterm infants and vitamin D supplement.

What This Means in Plain Language

This is a review of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).

The publication is from 2025 (Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page and the Copper (Supplement) compound page, all human trials.